Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2011 3
2012 4
2013 7
2014 6
2015 8
2016 4
2017 8
2018 4
2019 2
2020 7
2021 4
2022 6
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Mathematical approaches in estimating aptamer-target binding affinity.
Thevendran R, Navien TN, Meng X, Wen K, Lin Q, Sarah S, Tang TH, Citartan M. Thevendran R, et al. Among authors: sarah s. Anal Biochem. 2020 Jul 1;600:113742. doi: 10.1016/j.ab.2020.113742. Epub 2020 Apr 18. Anal Biochem. 2020. PMID: 32315616 Review.
The Application of Aptamers for Immunohistochemistry.
Bauer M, Macdonald J, Henri J, Duan W, Shigdar S. Bauer M, et al. Among authors: shigdar s. Nucleic Acid Ther. 2016 Jun;26(3):120-6. doi: 10.1089/nat.2015.0569. Epub 2016 Feb 10. Nucleic Acid Ther. 2016. PMID: 26862683 Review.
Aptamers: Cutting edge of cancer therapies.
Shigdar S, Schrand B, Giangrande PH, de Franciscis V. Shigdar S, et al. Mol Ther. 2021 Aug 4;29(8):2396-2411. doi: 10.1016/j.ymthe.2021.06.010. Epub 2021 Jun 17. Mol Ther. 2021. PMID: 34146729 Free PMC article. Review.
Aptamer-Based Diagnostics and Therapeutics.
Shigdar S. Shigdar S. Pharmaceuticals (Basel). 2019 Jan 2;12(1):6. doi: 10.3390/ph12010006. Pharmaceuticals (Basel). 2019. PMID: 30609700 Free PMC article.
Inflammation and cancer stem cells.
Shigdar S, Li Y, Bhattacharya S, O'Connor M, Pu C, Lin J, Wang T, Xiang D, Kong L, Wei MQ, Zhu Y, Zhou S, Duan W. Shigdar S, et al. Cancer Lett. 2014 Apr 10;345(2):271-8. doi: 10.1016/j.canlet.2013.07.031. Epub 2013 Aug 11. Cancer Lett. 2014. PMID: 23941828 Review.
Challenges and opportunities for siRNA-based cancer treatment.
Wang T, Shigdar S, Shamaileh HA, Gantier MP, Yin W, Xiang D, Wang L, Zhou SF, Hou Y, Wang P, Zhang W, Pu C, Duan W. Wang T, et al. Among authors: shigdar s. Cancer Lett. 2017 Feb 28;387:77-83. doi: 10.1016/j.canlet.2016.03.045. Epub 2016 Apr 1. Cancer Lett. 2017. PMID: 27045474 Review.
Radiolabelled Aptamers for Theranostic Treatment of Cancer.
Khalid U, Vi C, Henri J, Macdonald J, Eu P, Mandarano G, Shigdar S. Khalid U, et al. Among authors: shigdar s. Pharmaceuticals (Basel). 2018 Dec 24;12(1):2. doi: 10.3390/ph12010002. Pharmaceuticals (Basel). 2018. PMID: 30586898 Free PMC article. Review.
EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs.
Macdonald J, Henri J, Roy K, Hays E, Bauer M, Veedu RN, Pouliot N, Shigdar S. Macdonald J, et al. Among authors: shigdar s. Cancers (Basel). 2018 Jan 12;10(1):19. doi: 10.3390/cancers10010019. Cancers (Basel). 2018. PMID: 29329202 Free PMC article. Review.
Aptamers as potential therapeutic agents for ovarian cancer.
Henri JL, Macdonald J, Strom M, Duan W, Shigdar S. Henri JL, et al. Among authors: shigdar s. Biochimie. 2018 Feb;145:34-44. doi: 10.1016/j.biochi.2017.12.001. Epub 2017 Dec 7. Biochimie. 2018. PMID: 29224849 Review.
62 results